baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Call 210 4AB 21.03.../ DE000MB5MAC2 /

1/24/2025 6:23:14 PM	Chg.0.000	Bid10:00:38 PM	Ask10:00:38 PM	Underlying	Strike price	Expiration date	Option type
0.052EUR	0.00%	- Bid Size: -	- Ask Size: -	ABBVIE INC. D...	210.00 -	3/21/2025	Call

GlobeNewswire 8/29/2024 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...

GlobeNewswire 8/28/2024 Royalty Pharma to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference

GlobeNewswire 8/28/2024 Nxera Pharma Notes Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568

GlobeNewswire 8/23/2024 NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Confere...

GlobeNewswire 8/19/2024 TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults wit...

GlobeNewswire 8/15/2024 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...

GlobeNewswire 8/15/2024 Soleno Therapeutics Announces Updates to its Board of Directors

GlobeNewswire 8/14/2024 ArriVent BioPharma Reports Second Quarter 2024 Financial Results

GlobeNewswire 8/9/2024 Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2...

GlobeNewswire 8/8/2024 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/8/2024 Aligos Therapeutics Strengthens Board with Two New Independent Directors

GlobeNewswire 8/8/2024 Genmab Announces Financial Results for the First Half of 2024

GlobeNewswire 8/8/2024 Genmab Updates 2024 Financial Guidance

GlobeNewswire 8/8/2024 Royalty Pharma Reports Second Quarter 2024 Results

GlobeNewswire 8/7/2024 Alector Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/6/2024 Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/1/2024 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...

GlobeNewswire 8/1/2024 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024

GlobeNewswire 8/1/2024 NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer

GlobeNewswire 8/1/2024 Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc.

GlobeNewswire 7/31/2024 Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors

GlobeNewswire 7/31/2024 Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV111, a CD19 Directed in situ CAR...

GlobeNewswire 7/30/2024 Montara Therapeutics Closes $8 Million Seed Round Led by SV Health Investors’ Dementia Discovery Fun...

GlobeNewswire 7/28/2024 Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzhei...

GlobeNewswire 7/25/2024 Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Tre...

Morgan Stanley Call 210 4AB 21.03.../ DE000MB5MAC2 /

If you wish to receive reply to your feedback, please provide your email address.